Company profile
Coave Therapeutics
Coave therapeutics
- Industry
- Biotechnology Research
- Employees
- 53
- Headquarters
- Paris, Île-de-France
- Founded
- 2014
- LinkedIn followers
- 7,104
- Office locations
- 1
Coave Therapeutics company summary
Coave Therapeutics is a company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, founded in 2014. On LinkedIn the company has around 53 employees and 7,104 followers. Its listed specialties include médecine, thérapie génique, ophtalmologie, Gene Therapy, Rare Ocular disease.
What technology does Coave Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Coave Therapeutics
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.
Specialties
Where is Coave Therapeutics located?
Coave Therapeutics lists 1 location.
Compare companies similar to Coave Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Coave Therapeutics coavetx.com | Biotechnology Research | 53 | 2014 | Paris, Île-de-France |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Coave Therapeutics
What does Coave Therapeutics do?
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.
How many employees does Coave Therapeutics have?
Coave Therapeutics has around 53 employees on LinkedIn.
Where is Coave Therapeutics headquartered?
Coave Therapeutics is headquartered in Paris, Île-de-France.
When was Coave Therapeutics founded?
Coave Therapeutics was founded in 2014.
Build a lead list from companies like Coave Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.